Abstract
Prion diseases are a group of neurodegenerative disorders associated with the conformational conversion of the cellular prion protein (PrPC) into an abnormal misfolded form named PrPSc. Other than accumulating in the brain, PrPSc can bind PrPC and force it to change conformation to PrPSc. The exact mechanism which underlies the process of PrPC/PrPSc conversion still needs to be defined and many molecules or cofactors might be involved. Several studies have documented an important role of PrPC to act as receptor for abnormally folded forms of α-synuclein which are responsible of a group of diseases known as synucleinopathies. The presence of PrPC was required to promote efficient internalization and spreading of abnormal α-synuclein between cells. In this work, we have assessed whether α-synuclein exerts any role in PrPSc conversion and propagation either in vitro or in vivo. Indeed, understanding the mechanism of PrPC/PrPSc conversion and the identification of cofactors involved in this process is crucial for developing new therapeutic strategies. Our results showed that PrPSc was able to efficiently propagate in the brain of animals even in the absence of α-synuclein thus suggesting that this protein did not act as key modulator of prion propagation. Thus, α-synuclein might take part in this process but is not specifically required for sustaining prion conversion and propagation.
Similar content being viewed by others
References
Chesebro B (1999) Prion protein and the transmissible spongiform encephalopathy diseases. Neuron 24(3):503–506
Aguzzi A (2006) Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis. J Neurochem 97(6):1726–1739
Wulf MA, Senatore A, Aguzzi A (2017) The biological function of the cellular prion protein: an update. BMC Biol 15(1):34
Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95(23):13363–13383
Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73(7):1339–1347
Prusiner SB, Scott M, Foster D, Pan KM, Groth D, Mirenda C, Torchia M, Yang SL et al (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63(4):673–686
McKinley MP, Bolton DC, Prusiner SB (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35(1):57–62
Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z et al (1993) Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 90(23):10962–10966
Khalili-Shirazi A, Summers L, Linehan J, Mallinson G, Anstee D, Hawke S, Jackson GS, Collinge J (2005) PrP glycoforms are associated in a strain-specific ratio in native PrPSc. J Gen Virol 86(Pt 9):2635–2644
Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, Burton DR, DeArmond SJ, Prusiner SB et al (2002) A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 34(6):921–932
Cescatti M, Saverioni D, Capellari S, Tagliavini F, Kitamoto T, Ironside J, Giese A, Parchi P (2016) Analysis of conformational stability of abnormal prion protein aggregates across the spectrum of Creutzfeldt-Jakob disease prions. J Virol 90(14):6244–6254
Fraser H (1993) Diversity in the neuropathology of scrapie-like diseases in animals. Br Med Bull 49(4):792–809
DeArmond SJ, Sanchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V, Camerino AP, Cayetano J et al (1997) Selective neuronal targeting in prion disease. Neuron 19(6):1337–1348
Budka H (2003) Neuropathology of prion diseases. Br Med Bull 66:121–130
Fraser H, Dickinson AG (1968) The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol 78(3):301–311
Kovacs GG, Budka H (2008) Prion diseases: from protein to cell pathology. Am J Pathol 172(3):555–565
Dickinson AG, Meikle VM (1971) Host-genotype and agent effects in scrapie incubation: change in allelic interaction with different strains of agent. Mol Gen Genet 112(1):73–79
Hughes D, Halliday M (2017) What is our current understanding of PrP(Sc)-associated neurotoxicity and its molecular underpinnings? Pathogens 6(4)
Vilette D, Courte J, Peyrin JM, Coudert L, Schaeffer L, Andreoletti O, Leblanc P (2018) Cellular mechanisms responsible for cell-to-cell spreading of prions. Cell Mol Life Sci
Gousset K, Zurzolo C (2009) Tunnelling nanotubes: a highway for prion spreading? Prion 3(2):94–98
Nussbaum-Krammer CI, Park KW, Li L, Melki R, Morimoto RI (2013) Spreading of a prion domain from cell-to-cell by vesicular transport in Caenorhabditis elegans. PLoS Genet 9(3):e1003351
Costanzo M, Zurzolo C (2013) The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration. Biochem J 452(1):1–17
Hartmann A, Muth C, Dabrowski O, Krasemann S, Glatzel M (2017) Exosomes and the prion protein: more than one truth. Front Neurosci 11:194
Emamzadeh FN (2016) Alpha-synuclein structure, functions, and interactions. J Res Med Sci 21:29
Yu S, Li X, Liu G, Han J, Zhang C, Li Y, Xu S, Liu C et al (2007) Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience 145(2):539–555
Totterdell S, Meredith GE (2005) Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain. Neuroscience 135(3):907–913
Ostrerova N, Petrucelli L, Farrer M, Mehta N, Choi P, Hardy J, Wolozin B (1999) Alpha-synuclein shares physical and functional homology with 14-3-3 proteins. J Neurosci 19(14):5782–5791
Chen RH, Wislet-Gendebien S, Samuel F, Visanji NP, Zhang G, Marsilio D, Langman T, Fraser PE et al (2013) Alpha-synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity. J Biol Chem 288(11):7438–7449
Peng X, Tehranian R, Dietrich P, Stefanis L, Perez RG (2005) Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells. J Cell Sci 118(Pt 15):3523–3530
Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Sudhof TC (2010) Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329(5999):1663–1667
Pranke IM, Morello V, Bigay J, Gibson K, Verbavatz JM, Antonny B, Jackson CL (2011) Alpha-synuclein and ALPS motifs are membrane curvature sensors whose contrasting chemistry mediates selective vesicle binding. J Cell Biol 194(1):89–103
Witt SN (2010) Hsp70 molecular chaperones and Parkinson's disease. Biopolymers 93(3):218–228
Witt SN (2013) Molecular chaperones, alpha-synuclein, and neurodegeneration. Mol Neurobiol 47(2):552–560
Rekas A, Ahn KJ, Kim J, Carver JA (2012) The chaperone activity of alpha-synuclein: utilizing deletion mutants to map its interaction with target proteins. Proteins 80(5):1316–1325
Manning-Bog AB, McCormack AL, Purisai MG, Bolin LM, Di Monte DA (2003) Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J Neurosci 23(8):3095–3099
Zhu M, Qin ZJ, Hu D, Munishkina LA, Fink AL (2006) Alpha-synuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles. Biochemistry 45(26):8135–8142
Liu X, Lee YJ, Liou LC, Ren Q, Zhang Z, Wang S, Witt SN (2011) Alpha-synuclein functions in the nucleus to protect against hydroxyurea-induced replication stress in yeast. Hum Mol Genet 20(17):3401–3414
Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645):839–840
Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies. Neurosci Lett 251(3):205–208
Aulic S, Le TT, Moda F, Abounit S, Corvaglia S, Casalis L, Gustincich S, Zurzolo C et al (2014) Defined alpha-synuclein prion-like molecular assemblies spreading in cell culture. BMC Neurosci 15:69
Luk KC, Kehm V, Carroll J, Zhang B, O’Brien P, Trojanowski JQ, Lee VMY (2012) Pathological alpha-Synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109):949–953
Watts JC, Giles K, Oehler A, Middleton L, Dexter DT, Gentleman SM, DeArmond SJ, Prusiner SB (2013) Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci U S A 110(48):19555–19560
Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, Mann DM, Hasegawa M (2013) Prion-like spreading of pathological alpha-synuclein in brain. Brain 136(Pt 4):1128–1138
Tarutani A, Arai T, Murayama S, Hisanaga SI, Hasegawa M (2018) Potent prion-like behaviors of pathogenic alpha-synuclein and evaluation of inactivation methods. Acta Neuropathol Commun 6(1):29
Aulic S, Masperone L, Narkiewicz J, Isopi E, Bistaffa E, Ambrosetti E, Pastore B, De Cecco E et al (2017) Alpha-synuclein amyloids hijack prion protein to gain cell entry, facilitate cell-to-cell spreading and block prion replication. Sci Rep 7(1):10050
Urrea L, Segura-Feliu M, Masuda-Suzukake M, Hervera A, Pedraz L, Garcia-Aznar JM, Vila M, Samitier J et al (2018) Involvement of cellular prion protein in alpha-synuclein transport in neurons. Mol Neurobiol 55(3):1847–1860
Katorcha E, Makarava N, Lee YJ, Lindberg I, Monteiro MJ, Kovacs GG, Baskakov IV (2017) Cross-seeding of prions by aggregated alpha-synuclein leads to transmissible spongiform encephalopathy. PLoS Pathog 13(8):e1006563
Bartz JC, Bessen RA, McKenzie D, Marsh RF, Aiken JM (2000) Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J Virol 74(12):5542–5547
Bistaffa E, Moda F, Virgilio T, Campagnani I, De Luca CMG, Rossi M, Salzano G, Giaccone G et al (2018) Synthetic prion selection and adaptation. Mol Neurobiol
Baskakov IV (2014) The many shades of prion strain adaptation. Prion 8(2)
Katorcha E, Gonzalez-Montalban N, Makarava N, Kovacs GG, Baskakov IV (2018) Prion replication environment defines the fate of prion strain adaptation. PLoS Pathog 14(6):e1007093
Specht CG, Schoepfer R (2001) Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice. BMC Neurosci 2:11
Saborio GP, Permanne B, Soto C (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411(6839):810–813
Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A et al (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci 22(20):8797–8807
Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, Larsen KE, Staal R, Tieu K et al (2002) Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A 99(22):14524–14529
Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC (2005) Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123(3):383–396
Lindberg I, Shorter J, Wiseman RL, Chiti F, Dickey CA, McLean PJ (2015) Chaperones in neurodegeneration. J Neurosci 35(41):13853–13859
St Martin JL, Klucken J, Outeiro TF, Nguyen P, Keller-McGandy C, Cantuti-Castelvetri I, Grammatopoulos TN, Standaert DG et al (2007) Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra. J Neurochem 100(6):1449–1457
Nakamura S, Ono F, Hamano M, Odagiri K, Kubo M, Komatsuzaki K, Terao K, Shinagawa M et al (2000) Immunohistochemical detection of apolipoprotein E within prion-associated lesions in squirrel monkey brains. Acta Neuropathol 100(4):365–370
Hochstrasser DF, Frutiger S, Wilkins MR, Hughes G, Sanchez JC (1997) Elevation of apolipoprotein E in the CSF of cattle affected by BSE. FEBS Lett 416(2):161–163
Skinner PJ, Abbassi H, Chesebro B, Race RE, Reilly C, Haase AT (2006) Gene expression alterations in brains of mice infected with three strains of scrapie. BMC Genomics 7:114
Van Everbroeck B, Croes EA, Pals P, Dermaut B, Jansen G, van Duijn CM, Cruts M, Van Broeckhoven C et al (2001) Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt-Jakob disease phenotype. Neurosci Lett 313(1–2):69–72
Baumann MH, Kallijarvi J, Lankinen H, Soto C, Haltia M (2000) Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides. Biochem J 349(Pt 1):77–84
Moore RA, Timmes AG, Wilmarth PA, Safronetz D, Priola SA (2011) Identification and removal of proteins that co-purify with infectious prion protein improves the analysis of its secondary structure. Proteomics 11(19):3853–3865
Altmeppen HC, Puig B, Dohler F, Thurm DK, Falker C, Krasemann S, Glatzel M Proteolytic processing of the prion protein in health and disease. Am J Neurodegener Dis 2012(1, 1):15–31
Iida T, Doh-ura K, Kawashima T, Abe H, Iwaki T (2001) An atypical case of sporadic Creutzfeldt-Jakob disease with Parkinson's disease. Neuropathology 21(4):294–297
Haik S, Privat N, Adjou KT, Sazdovitch V, Dormont D, Duyckaerts C, Hauw JJ (2002) Alpha-synuclein-immunoreactive deposits in human and animal prion diseases. Acta Neuropathol 103(5):516–520
Adjou KT, Allix S, Ouidja MO, Backer S, Couquet C, Cornuejols MJ, Deslys JP, Brugere H et al (2007) Alpha-synuclein accumulates in the brain of scrapie-affected sheep and goats. J Comp Pathol 137(1):78–81
La Vitola P, Beeg M, Balducci C, Santamaria G, Restelli E, Colombo L, Caldinelli L, Pollegioni L et al (2019) Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects. Brain 142(2):249–254
Acknowledgments
The authors wish to thank Associazione Italiana Encefalopatie da Prioni (AIEnP).
Funding
This work was supported by the Italian Ministry of Health (RC) to F.M., Italian Ministry of Health to F.T., and Associazione Italiana Encefalopatie da Prioni (AIEnP).
Author information
Authors and Affiliations
Contributions
E.B. performed most of the experiments; M.R., C.D.L., performed part of the biochemical analysis; F.C., O.C. performed part of the histological analysis; I.C. was in charge of the animal care and sacrifice; F.T. and G.L. contributed in planning the experiments and in analyzing the data; and G.G. and F.M. supervised the work, analyzed the data and prepared the final version of the manuscript. All the authors read and approved the final manuscript.
Corresponding author
Ethics declarations
The study, including its Ethics aspects, was approved by the Italian Ministry of Health (Permit Number, NP-02-13).
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
ESM 1
(JPG 631 kb)
Rights and permissions
About this article
Cite this article
Bistaffa, E., Rossi, M., De Luca, C.M.G. et al. Prion Efficiently Replicates in α-Synuclein Knockout Mice. Mol Neurobiol 56, 7448–7457 (2019). https://doi.org/10.1007/s12035-019-1602-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-019-1602-6